Home/Filings/4/0001213900-25-052622
4//SEC Filing

Reznick Yehuda 4

Accession 0001213900-25-052622

CIK 0001176309other

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:08 PM ET

Size

6.7 KB

Accession

0001213900-25-052622

Insider Transaction Report

Form 4
Period: 2025-06-05
Transactions
  • Award

    Common Stock

    2025-06-05+8,37068,930 total
  • Award

    Common Stock

    2025-06-05+30,00060,560 total
Footnotes (2)
  • [F1]Represents Restricted Stock Units ("RSUs") that will vest in equal portions of 10,000 as follows: January 1, 2026, January 1, 2027 and January 1, 2028. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
  • [F2]Represents RSUs that will vest in equal installments as follows: on grant, July 1, 2025, October 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1
  • filerCIK 0002015556

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:08 PM ET
Size
6.7 KB